Abstract
In this issue of Blood, Yeomans et al identify MYC as an important target for translational regulation in chronic lymphocytic leukemia (CLL) cells after B-cell receptor (BCR) stimulation and show that current therapies suppress this induction.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have